5-butyl-3-(cyclohexylmethyl)-9-(1-(2,6-dimethylbenzoyl)piperidin-4-yl)-1-oxa-3,9-diazaspiro[5.5]undecan-2-one

ID: ALA1078753

PubChem CID: 11433740

Max Phase: Preclinical

Molecular Formula: C33H51N3O3

Molecular Weight: 537.79

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2

Standard InChI:  InChI=1S/C33H51N3O3/c1-4-5-14-28-24-36(23-27-12-7-6-8-13-27)32(38)39-33(28)17-21-34(22-18-33)29-15-19-35(20-16-29)31(37)30-25(2)10-9-11-26(30)3/h9-11,27-29H,4-8,12-24H2,1-3H3

Standard InChI Key:  TUOGNBAQCBUIHK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
    0.5542  -21.1833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9625  -21.8958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7792  -21.8984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1937  -21.1902    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7854  -20.4777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9625  -20.4734    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6986  -21.8608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1261  -21.8807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1605  -20.4555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6642  -20.4356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0962  -21.1405    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9187  -21.1192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3136  -20.3937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1348  -20.3731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5672  -21.0761    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1723  -21.8015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3450  -21.8240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3919  -21.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8232  -21.7575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7853  -20.3290    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6487  -21.7324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0868  -22.4348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6864  -23.1610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8574  -23.1803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4299  -22.4772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6051  -22.4962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0428  -21.0064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5477  -22.6090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9579  -23.3248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5432  -24.0379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9534  -24.7537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2009  -19.7650    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0187  -21.1940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4345  -20.4814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2579  -20.4884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6736  -19.7799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2679  -19.0612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4419  -19.0554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0217  -19.7684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  4  1  0
 18 19  1  0
  7 11  1  0
 18 20  2  0
  8  1  1  0
 19 21  2  0
  1  9  1  0
 21 22  1  0
  9 10  1  0
 22 23  2  0
 10 11  1  0
 23 24  1  0
 12 13  1  0
 24 25  2  0
 25 19  1  0
  4  5  1  0
 25 26  1  0
  5  6  1  0
 21 27  1  0
  7  8  1  0
  2 28  1  0
 28 29  1  0
  1  2  1  0
 29 30  1  0
  1  6  1  0
 30 31  1  0
 12 17  1  0
  5 32  2  0
 13 14  1  0
  4 33  1  0
 14 15  1  0
 33 34  1  0
 34 35  1  0
 15 16  1  0
 16 17  1  0
 11 12  1  0
  2  3  1  0
 15 18  1  0
 34 39  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
M  END

Associated Targets(Human)

CCR5 Tclin C-C chemokine receptor type 5 (5640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 537.79Molecular Weight (Monoisotopic): 537.3930AlogP: 6.58#Rotatable Bonds: 7
Polar Surface Area: 53.09Molecular Species: BASEHBA: 4HBD:
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.99CX LogP: 5.94CX LogD: 4.34
Aromatic Rings: 1Heavy Atoms: 39QED Weighted: 0.39Np Likeness Score: -0.31

References

1. Rotstein DM, Gabriel SD, Makra F, Filonova L, Gleason S, Brotherton-Pleiss C, Setti LQ, Trejo-Martin A, Lee EK, Sankuratri S, Ji C, Derosier A, Dioszegi M, Heilek G, Jekle A, Berry P, Weller P, Mau CI..  (2009)  Spiropiperidine CCR5 antagonists.,  19  (18): [PMID:19674898] [10.1016/j.bmcl.2009.07.122]

Source